600 mg, vaginal capsule, soft
Fenticonazole nitrate
Gynoxin Uno and Ломексин 600 mg are trade names of the same drug written in Polish and Bulgarian.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Gynoxin Uno contains the active substance fenticonazole, which is an imidazole derivative with a broad spectrum of antifungal activity, including against yeast. Fenticonazole also has antibacterial activity against Gram-positive and Gram-negative bacteria.
Indications for use
Fungal infections of the mucous membranes of the genital organs (vulvitis and vaginitis, vaginitis, discharge).
Treatment of mixed vaginal infections.
Gynoxin Uno is intended for use in adults and adolescents over 16 years of age.
Patient over 60 years of age should consult a doctor before using the medicine.
The vaginal capsule of Gynoxin Uno is intended for vaginal use only.
A reliable diagnosis of fungal infection and determination of the susceptibility of the microorganism to fenticonazole can only be made by a doctor. You should read the information in section 2 of the leaflet to determine when to consult a doctor before using the medicine.
Gynoxin Uno contains soybean lecithin. If the patient is allergic to peanuts or soy, they should not use this medicine.
The use of Gynoxin Uno should be discussed with a doctor or pharmacist if:
In the case of infection of the partner, their simultaneous treatment is recommended.
Gynoxin Uno is not intended for use in children and adolescents under 16 years of age.
Gynoxin Uno contains fats and oils that can damage mechanical contraceptives made of latex (condoms, vaginal diaphragms) (see "Warnings and precautions").
It is not recommended to use this medicine at the same time as spermicides (substances used vaginally that immobilize sperm and are used as contraception alone or together, e.g., with a diaphragm). Any local vaginal treatment can inactivate locally applied spermicides.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor before using this medicine. Gynoxin Uno should be used during pregnancy and breastfeeding under medical supervision.
Gynoxin Uno does not affect the ability to drive and use machines.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubt, you should consult a doctor or pharmacist.
The vaginal capsules of Gynoxin Uno are intended for vaginal use only.
The capsules should not be taken orally.
The recommended dose is:
Children and adolescents
The recommended dose for adolescents over 16 years of age is the same as for adults.
In case of swallowing a vaginal capsule, you should immediately contact a doctor or go to the nearest hospital.
In case of any further doubts about the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, Gynoxin Uno can cause side effects, although not everybody gets them.
After inserting the capsule into the vagina, a mild, transient burning sensation may occur.
If Gynoxin Uno is used as directed, the active substance is poorly absorbed, and the occurrence of systemic side effects is unlikely.
Locally applied medicines, especially when used for a long time, can cause allergies (see "Warnings and precautions" in section 2).
After using this medicine, the following side effects have been observed:
Very rare(less than 1 in 10,000):
Unknown(frequency cannot be estimated from the available data):
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or parallel importer.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
1 vaginal capsule, soft, in a PVC/PVDC/Aluminum blister pack, in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or parallel importer.
Recordati Ireland Ltd.
Raheens East, Ringaskiddy Co. Cork
Ireland
Catalent Italy S.p.A.
Via Nettunense Km 20, 100 – 04011 Aprilia (LT)
Italy
Allpharm Sp. z o.o. sp.k.
ul. M. Zdziechowskiego 11/4
02-659 Warsaw
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Marketing authorization number in Bulgaria, the country of export:20040138
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.